LONG-TERM SAFETY AND EFFICACY OF LISDEXAMFETAMINE DIMESYLATE BY AGE SUBGROUP IN CHILDREN AND ADOLESCENTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER

被引:0
|
作者
Coghill, D. [1 ]
Hernandez Otero, I. [2 ]
Nagy, P. [3 ,4 ]
Soutullo, C. A. [5 ]
Zuddas, A. [6 ]
Geibel, B. [7 ]
Naser, N. [8 ]
Yan, B. [7 ]
Banaschewski, T. [9 ]
机构
[1] Univ Dundee, Div Neurosci, Dundee, Scotland
[2] Maritime Hosp, Univ Hosp Virgen de la Victoria, Unit Child & Adolescent Mental Hlth USMIJ, Malaga, Spain
[3] Vadaskert Child & Adolescent Psychiat Hosp, Budapest, Hungary
[4] Outpatient Clin, Budapest, Hungary
[5] Univ Navarra Clin, Dept Psychiat & Med Psychol, Child & Adolescent Psychiat Unit, Pamplona, Spain
[6] Univ Cagliari, Dept Biomed Sci, Sect Neurosci & Clin Pharmacol, Cagliari, Italy
[7] Shire, Wayne, PA USA
[8] Shire, Sydney, NSW, Australia
[9] Heidelberg Univ, Med Fac Mannheim, Dept Child & Adolescent Psychiat & Psychotherapy, Cent Inst Mental Hlth, Mannheim, Germany
关键词
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:162 / 162
页数:1
相关论文
共 50 条
  • [21] The first European studies of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder
    Coghill, David
    Banaschewski, Tobias
    Lecendreux, Michel
    Soutullo, Cesar
    Johnson, Mats
    Zuddas, Alessandro
    Anderson, Colleen
    Civil, Richard
    Dauphin, Matthew
    Higgins, Nicholas
    Lyne, Andrew
    Gasior, Maria
    Squires, Liza
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2013, 22 : S125 - S125
  • [22] The first European studies of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder
    Coghill, D. R.
    Banaschewski, T.
    Lecendreux, M.
    Soutullo, C.
    Johnson, M.
    Zuddas, A.
    Anderson, C.
    Civil, R.
    Dauphin, M.
    Lyne, A.
    Gasior, M.
    Squires, L. A.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [23] Lisdexamfetamine dimesylate: a Treatment Option for Children and Adolescents with Attention Deficit/Hyperactivity Disorder in Germany and Across Europe
    Haege, A.
    Banaschewski, T.
    Dittmann, R. W.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2015, 83 (12) : 676 - 685
  • [24] Patterns of Lisdexamfetamine Dimesylate Use in Children, Adolescents, and Adults with Attention-Deficit/Hyperactivity Disorder in Europe
    Siffel, Csaba
    Page, Matthew
    Maxwell, Tricia
    Thun, Barbara
    Kolb, Nikolaus
    Rosenlund, Mats
    von Bredow, Dorothea
    Keja, Jacco
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2020, 30 (07) : 439 - 447
  • [25] An update on lisdexamfetamine dimesylate for the treatment of attention deficit hyperactivity disorder
    Wigal, Sharon B.
    Raja, Pooja
    Shukla, Ankita
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (01) : 137 - 145
  • [26] Lisdexamfetamine Dimesylate In Attention-Deficit Hyperactivity Disorder in Adults
    Weber, Juliane
    Siddiqui, M. Asif A.
    CNS DRUGS, 2009, 23 (05) : 419 - 425
  • [27] Efficacy and Safety of Lisdexamfetamine in Preschool Children With Attention-Deficit/Hyperactivity Disorder
    Childress, Ann C.
    Lloyd, Eric
    Jacobsen, Leslie
    Gunawardhana, Lhanoo
    Johnson, Steven A., Jr.
    Findling, Robert L.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2022, 61 (12): : 1423 - 1434
  • [28] Maintenance of Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: Randomized-Withdrawal Study Design
    Coghill, David R.
    Banaschewski, Tobias
    Lecendreux, Michel
    Johnson, Mats
    Zuddas, Alessandro
    Anderson, Colleen S.
    Civil, Richard
    Dauphin, Matthew
    Higgins, Nicholas
    Lyne, Andrew
    Gasior, Maria
    Squires, Liza A.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2014, 53 (06): : 647 - 657
  • [29] Long-Term Safety and Efficacy of Guanfacine Extended Release in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
    Sallee, Floyd R.
    Lyne, Andrew
    Wigal, Timothy
    McGough, James J.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2009, 19 (03) : 215 - 226
  • [30] Long-term safety and efficacy of guanfacine extended release in children and adolescents with Attention-Deficit/Hyperactivity disorder
    Sallee, Floyd
    McGough, James J.
    Wigall, Timothy
    Farrand, Kimberly
    Lyne, Andrew
    Biederman, Joseph
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 247S - 247S